These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7691639

  • 1. Interleukin-6 is a survival factor for committed myeloid progenitor cells.
    Kerst JM, Slaper-Cortenbach IC, van der Schoot CE, Hooibrink B, von dem Borne AE, van Oers RH.
    Exp Hematol; 1993 Nov; 21(12):1550-7. PubMed ID: 7691639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
    Kerst JM, Slaper-Cortenbach IC, von dem Borne AE, van der Schoot CE, van Oers RH.
    Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL, Bender JG, Maples PB, Unverzagt K, Schilling M, Lum L, Williams S, Van Epps DE.
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [Abstract] [Full Text] [Related]

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 8. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
    van de Ven C, Ishizawa L, Law P, Cairo MS.
    Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
    [Abstract] [Full Text] [Related]

  • 9. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV, Collins NH, Tafuri A, Keever CA.
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 11. Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture.
    Shull RM, Suggs SV, Langley KE, Okino KH, Jacobsen FW, Martin FH.
    Exp Hematol; 1992 Oct; 20(9):1118-24. PubMed ID: 1281786
    [Abstract] [Full Text] [Related]

  • 12. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S, Pettit GR, McCrady C.
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [Abstract] [Full Text] [Related]

  • 13. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 14. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
    Strauss LC, Welsh SB, Civin CI.
    Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
    [Abstract] [Full Text] [Related]

  • 15. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
    Hangoc G, Williams DE, Falkenburg JH, Broxmeyer HE.
    J Immunol; 1989 Jun 15; 142(12):4329-34. PubMed ID: 2656864
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 15; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 18. c-kit ligand combined with GM-CSF and/or IL-3 can expand CD34+ hematopoietic progenitor subsets for several weeks in vitro.
    Steen R, Mørkrid L, Tjønnfjord GE, Egeland T.
    Stem Cells; 1994 Mar 15; 12(2):214-24. PubMed ID: 7515297
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 20. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb 15; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.